Item List

The AI tool, DERM, analyses skin lesions to help doctors find cancers at an early stage. Already in use by several NHS trusts including Chelsea and Westminster NHS Foundation Trust, the highly accurate AI has helped over 38,000 NHS patients and detected more than 2,200 cancer cases to date.

This new funding will support Skin Analytics and NHS services to open three new skin cancer pathways across England, accessible via community hubs, meaning that thousands more patients will have access to the world-leading DERM skin cancer pathway later this year.